SCHEMBL324259

SCHEMBL324259

CNC(CCCl)(NC)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL254355 0.67
SCHEMBL18974038 0.61
SCHEMBL7205861 0.61
1,2-Dichloroethane SCHEMBL621620 0.60
SCHEMBL6818443 0.60
SCHEMBL1292843 0.60
SCHEMBL436635 0.60
SCHEMBL9861666 0.60
SCHEMBL9218495 0.60 ALDH1A1 (0.31)
1,2-Dichloroethane SCHEMBL10445508 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3389795-B1 OCCLUSIVE PERSONAL CARE COMPOSITION COLGATE PALMOLIVE CO (US) 2021-12-01 EP disclosed
EP-3389795-A1 OCCLUSIVE PERSONAL CARE COMPOSITION Colgate-Palmolive Company (US) 2018-10-24 EP disclosed
US-9861562-B2 Occlusive personal care composition COLGATE-PALMOLIVE COMPANY (US) 2018-01-09 US disclosed
US-9750719-B2 Tetrazole compounds as calcium channel blockers Convergence Pharmaceuticals Limited (GB) 2017-09-05 US disclosed
US-20170172868-A1 OCCLUSIVE PERSONAL CARE COMPOSITION COLGATE-PALMOLIVE COMPANY 2017-06-22 US disclosed
WO-2017105438-A1 OCCLUSIVE PERSONAL CARE COMPOSITION COLGATE-PALMOLIVE COMPANY (US) 2017-06-22 WO disclosed
US-20160015687-A1 TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited (GB) 2016-01-21 US disclosed
US-9115132-B2 Tetrazole compounds as calcium channel blockers Convergence Pharmaceuticals Limited (GB) 2015-08-25 US disclosed
EP-2665729-B1 PIPERAZINE DERIVATIVES AS CAV2.2 CALCIUM CHANNEL BLOCKERS CONVERGENCE PHARMACEUTICALS (GB) 2015-04-01 EP disclosed
US-8933132-B2 Tricyclic substituted benzenesulfonamide piperazine derivatives as CAV2.2 calcium channel blockers Convergence Pharmaceuticals Limited (GB) 2015-01-13 US disclosed
EP-2665729-A1 PIPERAZINE DERIVATIVES AS CAV2.2 CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited (GB) 2013-11-27 EP disclosed
US-20130210796-A1 TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited 2013-08-15 US disclosed
EP-2590953-A1 TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited (GB) 2013-05-15 EP disclosed
US-20130072499-A1 PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS Convergence Pharmaceuticals Limited 2013-03-21 US disclosed
EP-2533782-A1 PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS Convergence Pharmaceuticals Limited (GB) 2012-12-19 EP disclosed
WO-2012098400-A1 PIPERAZINE DERIVATIVES AS CAV2.2 CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited (GB) 2012-07-26 WO disclosed
WO-2012004604-A1 TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited (GB) 2012-01-12 WO disclosed
WO-2011086377-A1 PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS Convergence Pharmaceuticals Limited (GB) 2011-07-21 WO disclosed
EP-1907343-A2 PRODUCTION PROCESSES AND SYSTEMS, COMPOSITIONS, SURFACTANTS, MONOMER UNITS, METAL COMPLEXES, PHOSPHATE ESTERS, GLYCOLS, AQUEOUS FILM FORMING FOAMS, AND FOAM STABILIZERS GREAT LAKES CHEMICAL CORPORATION (US) 2008-04-09 EP disclosed
WO-2007016359-A2 PRODUCTION PROCESSES AND SYSTEMS, COMPOSITIONS, SURFACTANTS, MONOMER UNITS, METAL COMPLEXES, PHOSPHATE ESTERS, GLYCOLS, AQUEOUS FILM FORMING FOAMS, AND FOAM STABILIZERS GREAT LAKES CHEMICAL CORPORATION (US) 2007-02-08 WO disclosed